Skip to content

Teladoc Health, Inc.

TDOC · XNYS

CIK 1477449fmd_1HK8D16DDAMDGVGSXBD9CTTHSRServices · Services-Offices & Clinics of Doctors of MedicineTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 51 periods

Income Statement · Annual · Millions · USD
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues1232334185531,0942,0332,4072,6022,5702,530
Cost of revenue3262129184391650744–––
Net interest income(3)(17)(26)(29)(60)(80)(9)–––
Gross profit911722893697031,3821,663–––
Realized investment gains (losses)–––00600––
Research and development22345465165312334349307278
Operating income(63)(75)(71)(80)(506)(266)(13,653)(249)(1,021)(263)
Interest expense–––––8122222420
Interest and investment income–––––113475737
Other non-operating income (expense)–––0(1)5(1)4(6)10
Income before taxes(74)(107)(97)(109)(576)(385)(13,663)(220)(994)(236)
Income tax expense1(0)0(11)(91)44(4)18(35)
Net income from continuing operations(74)(107)(97)(99)(485)(429)(13,660)(220)(1,001)(200)
Net income(74)(107)(97)(99)(485)(429)(13,660)(220)(1,001)(200)
Net income to common shareholders(74)–––––––––
Teladoc Health, Inc. (TDOC) financial statements · FinancialMD